Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bespoke Extracts (BSPK) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Bespoke Extracts (BSPK) over the last 8 years, with Q3 2025 value amounting to $1.5 million.

  • Bespoke Extracts' Gains from Investment Securities fell 143.73% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 143.73%. This contributed to the annual value of $324000.0 for FY2024, which is 7930.16% down from last year.
  • Bespoke Extracts' Gains from Investment Securities amounted to $1.5 million in Q3 2025, which was down 143.73% from $1.5 million recorded in Q2 2025.
  • Bespoke Extracts' 5-year Gains from Investment Securities high stood at $172.2 million for Q2 2022, and its period low was -$859607.0 during Q3 2023.
  • In the last 5 years, Bespoke Extracts' Gains from Investment Securities had a median value of $900000.0 in 2023 and averaged $12.6 million.
  • As far as peak fluctuations go, Bespoke Extracts' Gains from Investment Securities tumbled by 10262.94% in 2023, and later skyrocketed by 269520.19% in 2024.
  • Quarter analysis of 5 years shows Bespoke Extracts' Gains from Investment Securities stood at -$500000.0 in 2021, then skyrocketed by 93.64% to -$31825.0 in 2022, then surged by 1387.06% to $409607.0 in 2023, then dropped by 20.9% to $324000.0 in 2024, then skyrocketed by 376.19% to $1.5 million in 2025.
  • Its Gains from Investment Securities was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.